Cardiovascular

Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results

Leslee Shaw
Leslee Shaw
Daniel Jones
Daniel Jones

REFERENCE: Abstract: Late Breaking Clinical Trials, Session 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
LESLEE SHAW, Emory University, Atlanta
COMMENT: DANIEL JONES, AHA President, University of Mississippi, Jackson

Some patients with stable angina may be best treated by adding percutaneous intervention to optimal medical therapy. This is the finding of a “nuclear sub-study” of the COURAGE (Clinical Outcomes Using Revascularization and Aggressive Drug Evaluation) trial. Although the study found no benefit of adding angioplasty in most patients, the AHA conference heard from Leslee Shaw that if myocardial ischemia is monitored using Single Photon Emission Computed Tomography (SPECT), there could be a role for angioplasty in a subgroup of patients. Peter Goodwin talked with Dr Shaw after her presentation and then asked the American Heart Association President, Daniel Jones, for his assessment.

Similar Interviews

  • Audio Journal of Cardiovascular Medicine:
    - COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help
    - ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk">Audio Journal of Cardiovascular Medicine:
    - COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help
    - ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk
  • STEVEN NISSEN, Cleveland Clinic, OH REFERENCE: N Engl J Med 2007 356 Reporting from: American College of Cardiolgy New Orleans Two big studies

  • Audio Journal of Cardiovascular Medicine: “COURAGE” Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?">Audio Journal of Cardiovascular Medicine: “COURAGE” Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?
  • HARVEY WHITE, Auckland City Hospital REFERENCE: ACC 2007 & N Engl J Med 356: March 2007 The finding from the COURAGE trial:

  • Chronic Stable Angina: Should ESC Guidelines on Clopidogrel as Pre-Treatment to Planned Coronary Angiography be Changed?
  • Post a comment

    Subscribe to Audio Medica Podcast